157 related articles for article (PubMed ID: 19645484)
1. The application of phosphoramidate protide technology to acyclovir confers anti-HIV inhibition.
Derudas M; Carta D; Brancale A; Vanpouille C; Lisco A; Margolis L; Balzarini J; McGuigan C
J Med Chem; 2009 Sep; 52(17):5520-30. PubMed ID: 19645484
[TBL] [Abstract][Full Text] [Related]
2. Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides.
Derudas M; Vanpouille C; Carta D; Zicari S; Andrei G; Snoeck R; Brancale A; Margolis L; Balzarini J; McGuigan C
J Med Chem; 2017 Sep; 60(18):7876-7896. PubMed ID: 28829913
[TBL] [Abstract][Full Text] [Related]
3. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of cyclosaligenyl prodrugs of acyclovir, carbovir and abacavir.
Balzarini J; Haller-Meier F; De Clercq E; Meier C
Antivir Chem Chemother; 2001 Sep; 12(5):301-6. PubMed ID: 11900349
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral evaluation of phosphoramidate derivatives of (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Harris SA; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Antivir Chem Chemother; 2001 Sep; 12(5):293-300. PubMed ID: 11900348
[TBL] [Abstract][Full Text] [Related]
6. Phosphoramidate derivatives of stavudine as inhibitors of HIV: unnatural amino acids may substitute for alanine.
McGuigan C; Bidois L; Hiouni A; Ballatore C; De Clercq E; Balzarini J
Antivir Chem Chemother; 2000 Mar; 11(2):111-6. PubMed ID: 10819435
[TBL] [Abstract][Full Text] [Related]
7. A new class of dual-targeted antivirals: monophosphorylated acyclovir prodrug derivatives suppress both human immunodeficiency virus type 1 and herpes simplex virus type 2.
Vanpouille C; Lisco A; Derudas M; Saba E; Grivel JC; Brichacek B; Scrimieri F; Schinazi R; Schols D; McGuigan C; Balzarini J; Margolis L
J Infect Dis; 2010 Feb; 201(4):635-43. PubMed ID: 20085496
[TBL] [Abstract][Full Text] [Related]
8. The phosphoramidate ProTide approach greatly enhances the activity of beta-2'-C-methylguanosine against hepatitis C virus.
McGuigan C; Perrone P; Madela K; Neyts J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4316-20. PubMed ID: 19523820
[TBL] [Abstract][Full Text] [Related]
9. An investigation into the anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U) and 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives.
Mehellou Y; Balzarini J; McGuigan C
Org Biomol Chem; 2009 Jun; 7(12):2548-53. PubMed ID: 19503928
[TBL] [Abstract][Full Text] [Related]
10. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells.
Mehellou Y; Balzarini J; McGuigan C
ChemMedChem; 2009 Nov; 4(11):1779-91. PubMed ID: 19760699
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anti-herpetic activity of phosphoramidate ProTides.
Maiti M; Persoons L; Andrei G; Snoeck R; Balzarini J; Herdewijn P
ChemMedChem; 2013 Jun; 8(6):985-93. PubMed ID: 23606629
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues.
Lisco A; Vanpouille C; Tchesnokov EP; Grivel JC; Biancotto A; Brichacek B; Elliott J; Fromentin E; Shattock R; Anton P; Gorelick R; Balzarini J; McGuigan C; Derudas M; Götte M; Schinazi RF; Margolis L
Cell Host Microbe; 2008 Sep; 4(3):260-270. PubMed ID: 18779052
[TBL] [Abstract][Full Text] [Related]
13. Polyfluoroaromatic stavudine (d4T) ProTides exhibit enhanced anti-HIV activity.
Kandil S; Pannecouque C; Chapman FM; Westwell AD; McGuigan C
Bioorg Med Chem Lett; 2019 Dec; 29(24):126721. PubMed ID: 31679972
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and anti-HIV activity of 2',3'-didehydro-2',3'-dideoxyuridine (d4U), 2',3'-dideoxyuridine (ddU) phosphoramidate 'ProTide' derivatives.
Mehellou Y; McGuigan C; Brancale A; Balzarini J
Bioorg Med Chem Lett; 2007 Jul; 17(13):3666-9. PubMed ID: 17485204
[TBL] [Abstract][Full Text] [Related]
15. A QSAR study investigating the effect of L-alanine ester variation on the anti-HIV activity of some phosphoramidate derivatives of d4T.
Knaggs MH; McGuigan C; Harris SA; Heshmati P; Cahard D; Gilbert IH; Balzarini J
Bioorg Med Chem Lett; 2000 Sep; 10(18):2075-8. PubMed ID: 10999474
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro enzymatic and antiviral evaluation of phosphoramidate d4T derivatives as chain terminators.
Yang S; Pannecouque C; Lescrinier E; Giraut A; Herdewijn P
Org Biomol Chem; 2012 Jan; 10(1):146-53. PubMed ID: 22069085
[TBL] [Abstract][Full Text] [Related]
17. Novel thiosemicarbazones derived from formyl- and acyldiazines: synthesis, effects on cell proliferation, and synergism with antiviral agents.
Easmon J; Heinisch G; Holzer W; Rosenwirth B
J Med Chem; 1992 Aug; 35(17):3288-96. PubMed ID: 1354751
[TBL] [Abstract][Full Text] [Related]
18. Exploiting the anti-HIV-1 activity of acyclovir: suppression of primary and drug-resistant HIV isolates and potentiation of the activity by ribavirin.
Vanpouille C; Lisco A; Introini A; Grivel JC; Munawwar A; Merbah M; Schinazi RF; Derudas M; McGuigan C; Balzarini J; Margolis L
Antimicrob Agents Chemother; 2012 May; 56(5):2604-11. PubMed ID: 22314523
[TBL] [Abstract][Full Text] [Related]
19. Phosphoramidates and phosphonamidates (ProTides) with antiviral activity.
Slusarczyk M; Serpi M; Pertusati F
Antivir Chem Chemother; 2018; 26():2040206618775243. PubMed ID: 29792071
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of lipophilic phosphoramidate d4T-MP prodrugs expressing high potency against HIV in cell culture: structural determinants for in vitro activity and QSAR.
Siddiqui AQ; McGuigan C; Ballatore C; Zuccotto F; Gilbert IH; De Clercq E; Balzarini J
J Med Chem; 1999 Oct; 42(20):4122-8. PubMed ID: 10514282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
